• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GE HealthCare showcases commitment to sustainable innovation at RSNA 2024

    12/4/24 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    • Determined to reach net zero emissions by 2050, GE HealthCare's portfolio features environmentally conscious product design, energy efficiency, and technology circularity while continuing to drive advancements in patient care

    As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (NASDAQ:GEHC) is highlighting several solutions with increased focus on sustainability at the Radiological Society of North America (RSNA) 2024 Annual Meeting, which is held Dec. 1-4 in Chicago, IL.

    "With a deep appreciation for the importance of sustainability, at GE HealthCare, we are managing our environmental footprint by integrating sustainability into our business while also decreasing operational costs through energy efficiency and waste reduction," said Roland Rott, president and CEO of Imaging, GE HealthCare. "More than one billion patients worldwide are touched by one of our products or care solutions annually – a responsibility we take very seriously as the actions we take now will impact our planet and global population for decades and centuries to come."

    Since becoming an independent company, GE HealthCare has continued to strengthen its legacy of improving the quality of life of people around the world. In 2023, the company reduced its overall greenhouse gas emissions by 13% as part of a strategy validated by the Science Based Targets initiative that seeks to achieve net zero carbon emissions by 2050. Additionally, that same year, the company also recovered 7,375 imaging, ultrasound, and surgery machines, leading to more than 15 million pounds of reused and recycled material.

    Circulatory and environmentally conscious design

    Through initiatives like the Circularity and Environmentally Conscious Design program, GE HealthCare works to extend the lifespan of products to serve customers and patients for as long as possible. For example, in many cases, magnetic resonance imaging (MRI) scanner magnets can be kept in place during equipment upgrades, eliminating the need for a new magnet and reducing the environmental impact associated with manufacturing and transportation. When some systems have reached the end of their lifecycle, dedicated teams may be available to manage the recycling and refurbishing to help keep waste out of landfills.

    Sustainable innovations in remote scanning and pharmaceutical diagnostics

    GE HealthCare also offers technologies that enable remote clinician training and remote patient scanning, such as Digital Expert Access with remote scanning and nCommand Lite by IONIC Health (exclusively distributed by GE HealthCare), which help support sustainability initiatives of hospitals and health systems.

    "By leveraging more remote collaboration and scanning options, such as Digital Expert Access and nCommand Lite by IONIC Health, radiology administrators can streamline workflows and increase efficiency," said Rekha Ranganathan, senior vice president, general manager, Imaging Platforms and Digital Solutions, GE HealthCare. "Having an expert technologist who can support the optimization of scan parameters, as well as improve throughput and reduce patient rescans, could also contribute to energy efficiency in healthcare systems."

    In the pharmaceutical diagnostics space, the CT motion™ syringeless power injector for iodinated contrast media improves patient throughput and greatly reduces overall plastic waste and contrast waste through optimizing contrast administration. A large academic hospital, University of Wisconsin - Madison, compared CT motion with a typical syringe-based injector and found it reduced their plastic waste by 84.6% (~3 tons) and eliminated their contrast media waste (31.3L) over the course of 16 weeks.i*

    Additionally, in October, GE HealthCare announced the completion of its Phase I clinical development program for a first-of-its-kind manganese-based macrocyclic MRI contrast agent. Along with its suitable image-enhancing properties, this manganese-based agent could be a viable option to gadolinium, particularly in light of perceived concerns relating to gadolinium retention and the potential impact of post-patient excreted gadolinium in the environment.

    Supporting sustainability across the GE HealthCare portfolio

    During RSNA, GE HealthCare is featuring innovations designed with sustainability in mind, including:

    • CT motion & MR Max 3™ – syringeless power injectors for the CT and MR radiology suite, compatible with multiple contrast container sizes and/or concentrations. These syringeless injectors enhance workflow efficiency, lower plastic waste consumption, and enable contrast optimization through the efficient use of Imaging Bulk Packaging containers, thus further reducing overall departmental cost by reducing contrast waste.
    • SIGNA™ Champion – this system is GE HealthCare's smallest footprint and most power efficient 1.5T wide bore system. Enabling shorter scans times, the system reduces power demands, increases throughput, and enhances the overall patient experience. With its highly scalable platform, SIGNA Champion supports broader affordability, configurability, and upgradability to support services expansion for health systems.
    • Vscan Air – this ultrasound system is designed to be refurbished, reused, or recycled at the end of its product life to minimize unnecessary waste. The product is manufactured in GE HealthCare's Zipf, Austria, a facility that uses 100% renewable electricity.
    • Revolution™ Apex platform – now boasts Energy Saving Mode 2.0, which transitions the scanner into low power mode during extended periods of non-operation to help reduce power consumption by approximately 80% in unit kW, and can achieve over a 30% reductionii in daily energy consumption (in kWh).
    • Revolution™ Ascend platform and Revolution™ Maxima – these CT systems within the Revolution family reduce energy consumption by up to 15% and lower indirect carbon emissions by 68% when using energy savings mode.
    • AMX™ Navigateiii– this X-ray system battery charges from 0% to 100% in 4.5 hours and can take up to 350 images over 4.6 hours without being plugged into a power outlet.
    • Omni Legend PET/CT – this system, when idle, reduces energy consumption by up to 50% when using the standby power mode. In addition, the replacement X-ray tube for the Revolution Maxima can recycle 47% of the mass of the X-ray tube, enabling savings on energy and natural resources.

    Sustainability beyond RSNA

    In addition to the products being showcased at RSNA, GE HealthCare is furthering its commitment to sustainability by pioneering new breakthroughs to lead the green anesthesia movement. Gasses commonly used for anesthesia are recognized greenhouse gasses that contribute to global warming and can damage the Earth's ozone layer, and according to the American Association of Nurse Anesthesiology, one-quarter of a hospital's operating room waste is from anesthesiaiv. GE HealthCare's End-tidal Control** software automatically adjusts and maintains exhaled oxygen and exhaled anesthetic concentrations, with more accuracy in reaching the clinician's target versus manual control. By significantly reducing anesthetic agent usage, End-tidal Control can help reduce greenhouse gas emissions and costs, compared to conventional manual control. One study showed a potential 44% decline in the rate of greenhouse emissions when employing End-tidal Control software.v

    For more information on GE HealthCare's sustainability initiatives, and these innovative solutions showcased at RSNA, please visit Booth 7330, the company's RSNA press kit or the GE HealthCare sustainability page.

    *Results are unique to UW-Madison's analysis and may not be extrapolated or generalized to other settings.

    **End-tidal Control in the United States is indicated for patients 18 years of age and older.

    About GE HealthCare Technologies Inc.

    GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

    Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

    ________________________________________

    i
    Toia GV, Rose SD, Brown Z, Dovalis D, Bartels CM, Bladorn RM, Schluter KL, Lubner MG, Szczykutowicz TP. Consumable Material Waste and Workflow Efficiency Comparison Between Multi-use Syringeless and Single-use Syringe-Based Injectors in Computed Tomography. Acad Radiol. 2023 Oct;30(10):2340-2349. doi: 10.1016/j.acra.2023.05.038. Epub 2023 Jun 26. PMID: 37380534.

    ii Energy saving 2.0 according to the COCIR SRI 2015 for CT, which simulate 24 hours of daily use with 20 patients scans and 12 hours in low power mode.

    iii AMX Navigate Data Sheet, data on file (https://gehealthcare.box.com/s/s06lwq2w5svpqzzk57vu29qa54vmywzr)

    iv https://pubmed.ncbi.nlm.nih.gov/31920201/

    v Tay S, Weinberg L, Peyton P, Story D, Briedis J. Financial and environmental costs of manual versus automated control of end-tidal gas concentrations. Anaesthesia Intensive Care. 2013 Jan;41(1):95-101. doi:10.1177/0310057X1304100116. PMID: 23362897.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241204537469/en/

    Get the next $GEHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What are GE HealthCare's sustainability commitments and goals?

      GE HealthCare is committed to achieving net zero carbon emissions by 2050 through sustainable product design and innovations, prominently featured during the RSNA 2024 Annual Meeting.

    • What products is GE HealthCare showcasing at RSNA 2024 that focus on sustainability?

      GE HealthCare highlights its sustainability efforts by showcasing products like CT motion, MR Max, and SIGNA Champion at the RSNA 2024 Annual Meeting, designed to enhance efficiency while minimizing environmental impact.

    • What achievements has GE HealthCare made in terms of emissions reduction and recycling?

      In 2023, GE HealthCare reduced its greenhouse gas emissions by 13% and recovered over 7,375 imaging machines, reusing and recycling more than 15 million pounds of materials as part of its circular economy initiatives.

    • How does GE HealthCare's remote technology contribute to sustainability in healthcare?

      Remote technologies like Digital Expert Access and nCommand Lite enhance clinical efficiency and support sustainability by optimizing workflows and reducing energy consumption in healthcare settings.

    • What is the impact of GE HealthCare's End-tidal Control software on greenhouse gas emissions?

      The End-tidal Control software from GE HealthCare significantly decreases the use of anesthetic agents, potentially reducing greenhouse emissions by up to 44% compared to conventional methods.

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    1/15/2026$77.00Neutral → Sell
    UBS
    10/13/2025$86.00Equal Weight
    Barclays
    10/7/2025$83.00Buy → Neutral
    Citigroup
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    More analyst ratings

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    5/2/24 6:00:38 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

    SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in remote settings. SIGNA Bolt, a new 3T MRI scanner, is engineered to support precision diagnostics, clinical efficiency, and advanced research capability. Both new systems are powered by SIGNA One, an ecosystem of AI-driven workflow solutions designed to reduce inefficiencies and support MRI exams from plan to scan and beyond. GE HealthCare (NASDAQ:GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with the U.S. Food and Drug Administration (FDA): SIGNA™

    2/19/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness

    GE HealthCare (NASDAQ:GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded agreement builds on the existing program announced in October 2023 and reflects continued momentum to develop artificial intelligence (AI)-powered ultrasound solutions and new platforms to support trauma assessment and preparedn

    2/17/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GE HealthCare downgraded by UBS with a new price target

    UBS downgraded GE HealthCare from Neutral to Sell and set a new price target of $77.00

    1/15/26 8:32:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    Barclays initiated coverage on GE HealthCare with a new price target

    Barclays initiated coverage of GE HealthCare with a rating of Equal Weight and set a new price target of $86.00

    10/13/25 8:53:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare downgraded by Citigroup with a new price target

    Citigroup downgraded GE HealthCare from Buy to Neutral and set a new price target of $83.00

    10/7/25 8:57:17 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Newcomb George A. was granted 2,523 shares and covered exercise/tax liability with 802 shares, increasing direct ownership by 23% to 9,318 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    2/17/26 7:18:22 PM ET
    $GEHC
    Medical Electronics
    Health Care

    CEO, PDx O'Neill Kevin Michael was granted 6,938 shares and covered exercise/tax liability with 3,261 shares, increasing direct ownership by 16% to 26,195 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    2/17/26 7:17:50 PM ET
    $GEHC
    Medical Electronics
    Health Care

    CEO, AVS Rackliffe Philip was granted 3,154 shares and covered exercise/tax liability with 1,174 shares, increasing direct ownership by 13% to 17,373 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    2/17/26 7:17:11 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.

    SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    2/13/26 1:22:49 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form 10-K filed by GE HealthCare Technologies Inc.

    10-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

    2/4/26 6:28:06 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

    2/4/26 6:25:33 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    View All

    PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

    BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025. Mr. Montagut brings over 25 years of senior leadership experience in the pharmaceutical sector, with a solid track record of driving growth and executing strategic transformation across glob

    6/2/25 8:00:00 AM ET
    $GEHC
    $LNTH
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

    GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

    4/9/25 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

    Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has become essential Enhancing Elekta's radiation therapy offerings with GE HealthCare's MIM Software medical imaging management solutions will help drive greater benefits for global healthcare systems This new collaboration complements GE HealthCare and Elekta's existing global commercial collaboration agreement, which enables the two companies to provide hospitals and cancer patients a comprehensive radiation therapy offering across imaging and treatment Weeks after closing its acquisition of MIM Software – a global provider of medical imaging analy

    4/22/24 7:07:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Financials

    Live finance-specific insights

    View All

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare reports fourth quarter and full year 2025 financial results

    Company exceeds topline and earnings per share expectations; demonstrates operational resilience Fourth quarter 2025 highlights(1) Revenue growth of 7.1%, including Organic revenue growth* of 4.8%, driven primarily by the U.S. and Europe, the Middle East and Africa (EMEA) Net income margin of 10.3% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.7% Diluted earnings per share (EPS) of $1.29 and Adjusted EPS* of $1.44 Cash flow from operating activities of $1.0 billion and Free cash flow* of $916 million Full year 2025 highlights(1) Revenue growth of 4.8%, including Organic revenue growth* of 3.5% Organic orders growth of 5.2% Net income margin o

    2/4/26 6:20:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026

    GE HealthCare (NASDAQ:GEHC) will announce its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February 4, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innova

    1/5/26 8:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    11/12/24 12:53:28 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    10/22/24 4:16:16 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    4/2/24 4:07:29 PM ET
    $GEHC
    Medical Electronics
    Health Care